3-38550400-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_000335.5(SCN5A):c.5969G>A(p.Arg1990Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000204 in 1,567,818 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000335.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SCN5A | NM_001099404.2 | c.5972G>A | p.Arg1991Gln | missense_variant | 28/28 | ENST00000413689.6 | NP_001092874.1 | |
SCN5A | NM_000335.5 | c.5969G>A | p.Arg1990Gln | missense_variant | 28/28 | ENST00000423572.7 | NP_000326.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.5972G>A | p.Arg1991Gln | missense_variant | 28/28 | 5 | NM_001099404.2 | ENSP00000410257.1 | ||
SCN5A | ENST00000423572.7 | c.5969G>A | p.Arg1990Gln | missense_variant | 28/28 | 1 | NM_000335.5 | ENSP00000398266.2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152222Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000184 AC: 26AN: 1415478Hom.: 0 Cov.: 31 AF XY: 0.0000201 AC XY: 14AN XY: 696932
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152340Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74484
ClinVar
Submissions by phenotype
not provided Uncertain:4Other:1
Uncertain significance, no assertion criteria provided | provider interpretation | Stanford Center for Inherited Cardiovascular Disease, Stanford University | Jun 06, 2016 | c.5972G>A (p.Arg1991Gln) in SCN5A (NM_198056.2) Invitae classifies this variant as as a variant of unknown significance. Given the lack of case data, presence in ethnically matched controls, and presence in a case with another very likely pathogenic variant, we consider this variant to be a variant of unknown significance and we do not feel it is suitable for assessing risk in healthy relatives ("predictive genetic testing"). We have seen this variant in a patient with DCM and a very likely pathogenic LMNA variant. Testing was done by Invitae. The variant has not been reported in a case of cardiomyopathy, but has been seen in published control populations that are ethnically matched to our patient: 1/1300 people (Kapa 2007, Kapplinger 2010) and 1/96 Kenyan people by the 1000 Genomes Project (dbSNP rs199473336). There is no variation at codon 1991 listed in the Exome Aggregation Consortium dataset (http://exac.broadinstitute.org/), which currently includes variant calls on ~64,000 individuals of European, African, Latino and Asian descent (as of 6/7/2016). The mean coverage at that site in ExAC is 70x and the median coverage is 80x, with ~90% of people having 25x coverage. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 05, 2024 | This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1991 of the SCN5A protein (p.Arg1991Gln). This variant is present in population databases (rs199473336, gnomAD 0.007%). This missense change has been observed in individual(s) with clinical features of SCN5A-related conditions (PMID: 17438610, 33500567). ClinVar contains an entry for this variant (Variation ID: 68021). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | May 22, 2020 | Reported in ClinVar as a variant of uncertain significance by several clinical laboratories; reportedly identified in a patient with DCM who also harbored a likely pathogenic variant in the LMNA gene (ClinVar Variant ID#68021; SCV000924943.1; Landrum et al., 2016); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 32048431, 25904541, 26332594, 20129283, 19841300) - |
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported in the following publications (PMID:17438607;PMID:19841300;PMID:20129283). - |
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 30, 2022 | The p.Arg1991Gln variant in SCN5A has been identified by our laboratory in 1 African American individual with LVNC (also reported in Mazzarotto 2021). This variant has also been identified in 1/2600 Black control chromosomes (Kapa 2007, Kapplinger 2010), 1/15000 European chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org), and 1/198 Kenyan chromosomes by the 1000 Genomes project (dbSNP rs199473336). This variant has also been reported in ClinVar (Variation ID 68021). Computational prediction tools and conservation analysis suggest that the p.Arg1991Gln variant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, the clinical significance of the p.Arg1991Gln variant is uncertain. ACMG/AMP Criteria applied: PM2_Supporting, BP4. - |
Cardiac arrhythmia Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Apr 25, 2024 | This missense variant replaces arginine with glutamine at codon 1991 of the SCN5A protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been performed for this variant. This variant has been reported in two individuals affected with long QT syndrome (PMID: 17438610, 21185501), as well as in several ostensibly healthy individuals (PMID: 19841300, 20129283, 25904541, Aguib et al., 2019). This variant has been identified in 2/31398 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Jan 20, 2023 | This missense variant replaces arginine with glutamine at codon 1991 of the SCN5A protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been performed for this variant. This variant has been reported in two individuals affected with long QT syndrome (PMID: 17438610, 21185501), as well as in several ostensibly healthy individuals (PMID: 19841300, 20129283, 25904541, Aguib et al., 2019). This variant has been identified in 2/31398 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
SUDDEN INFANT DEATH SYNDROME;C1832680:Dilated cardiomyopathy 1E;C1837845:Sick sinus syndrome 1;C1859062:Long QT syndrome 3;C1879286:Progressive familial heart block, type 1A;C2751898:Ventricular fibrillation, paroxysmal familial, type 1;C3151464:Atrial fibrillation, familial, 10;C4551804:Brugada syndrome 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Nov 05, 2021 | - - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 10, 2022 | The c.5972G>A (p.R1991Q) alteration is located in exon 28 (coding exon 27) of the SCN5A gene. This alteration results from a G to A substitution at nucleotide position 5972, causing the arginine (R) at amino acid position 1991 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at